Neuromodulation treatments for migraine: a contemporary update

Author:

Kramer Jeffery12,Hayek Salim3,Levy Robert4

Affiliation:

1. Volta Research, Minneapolis, Minnesota

2. University of Illinois, Chicago, Illinois

3. Case Western Reserve University, Cleveland, Ohio

4. Neurosurgery and Clinical Research, Anesthesia Pain Care Consultants, Inc, Tamarac, Florida, USA

Abstract

Purpose of review Neuromodulation approaches have been a part of a revolution in migraine therapies with multiple devices approved or in development. These devices vary in the nerve(s) being targeted, implantable versus noninvasive form factors as well as their effectiveness for acute pain reduction or migraine prevention. This review will summarize these recent advancements and approaches that are being developed which build upon prior work and improved technology that may help enhance the effectiveness as well as the patient experience. Recent findings Both noninvasive and implantable devices primarily targeting cranial nerves have shown the ability to help alleviate migraine symptoms. Multiple prospective and retrospective studies have demonstrated clinically meaningful reductions in headache intensity with noninvasive approaches, while prevention of migraine demonstrates more modest effects. Implantable neuromodulation technologies focusing on occipital and supraorbital stimulation have shown promise in migraine/headache prevention in chronic migraine patients, but there is a need for improvements in technology to address key needs for surgical approaches. Summary Electrical neuromodulation approaches in the treatment of migraine is undergoing a transformation towards improved outcomes with better technologies that may suit various patient needs on a more individualized basis.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference45 articles.

1. Migraine: disease characterisation, biomarkers, and precision medicine;Ashina;Lancet,2021

2. Potential treatment targets for migraine: emerging options and future prospects;Chiang;Lancet Neurol,2024

3. Neuromodulation techniques for headache management;Reffat;Life (Basel),2024

4. Migraine;Ferrari;Nat Rev Dis Primers,2022

5. Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions;Al-Hassany;Lancet Neurol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3